Among patients with HR+/HER2– breast cancer, UBE2C expression did not differ between pN0 and pN1 tumors, whereas it was higher in pN2/N3 tumors than in pN0 and pN1 tumors (Figure 2B). This evidence concerns the gene UBE2C and breast cancer.